Kenvue

Kenvue Enhances Board Dynamics with Starboard CEO Appointment in Proxy Fight Settlement

29 days ago

In a significant development within the corporate governance landscape, Kenvue Inc. has appointed the CEO of Starboard Value, Jeff Smith, to its board of directors as part of a settlement aimed at resolving a contentious proxy fight. This strategic move underscores Kenvue's commitment to fortifying its governance framework, ensuring that the company navigates its future challenges with robust oversight.

Waste Management, Diageo, and Kenvue Face Challenges Amid Tariff Scenarios

2 months ago

In a rapidly evolving economic landscape, major corporations such as Waste Management, Diageo, and Kenvue are navigating complex tariff situations that could significantly impact their operations and profit margins. Recent discussions around potential tariffs have led these companies to develop strategic responses to safeguard their interests while maintaining their market positions.

Kenvue Faces Challenges as Sales Fall Short of Expectations Amid Weak Volume for Tylenol

2 months ago

Kenvue, the consumer health division of Johnson & Johnson, has recently reported disappointing sales results that failed to meet Wall Street's projections. This trend has raised concerns among investors regarding the company's performance, particularly its flagship products like Tylenol, which are experiencing declining volumes in the market.

Kenvue Faces Pressure as Weak Sales Fuel Activist Investor Battle

5 months ago

Kenvue Holdings, the consumer health subsidiary of Johnson & Johnson, has recently reported disappointing sales results that have intensified the ongoing confrontations with Starboard Value, a prominent activist investment firm. The latest quarterly results revealed a decline in product sales, further complicating Kenvue's efforts to stabilize its market position following its split from J&J earlier this year.

Starboard Value Takes Stake in Kenvue, Pushing for Strategic Changes

6 months ago

In a development that has caught the eye of investors and market analysts alike, activist investment firm Starboard Value has acquired a significant stake in Kenvue Inc., the consumer health division spun off from Johnson & Johnson. This move signals Starboard’s ambition to implement strategic changes within the company to enhance its performance and shareholder value, according to a report published by The Wall Street Journal.